NCT07030855View on ClinicalTrials.gov

Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Acute Bronchitis
Interventions
COMBINATION_PRODUCT

Elixirium thymi compositum (FoNo VIII.)

During the study, the dosage is for children and adolescents as follows: 6 ml three times a day for 6-9 years, 8 ml three times a day for 9-15 years, and 10 ml three times a day for 15-17 years.

COMBINATION_PRODUCT

Elixirium thymi compositum (FoNo VIII.) placebo

During the study, the dosage is for children and adolescents as follows: 6 ml three times a day for 6-9 years, 8 ml three times a day for 9-15 years, and 10 ml three times a day for 15-17 years.

Trial Locations (1)

Unknown

Noé Medical Center, Szeged

All Listed Sponsors
lead

Semmelweis University

OTHER